Terns Pharmaceuticals, Inc.

Q2 2022 13F Holders

Symbol
TERN
CUSIP
880881107
Type
Equity
Class
COM
Num filings
43
Total reported value, excl. options
$36.6 M
Manager Report Date Value ($000) Shares Option Type